angeles commentary 4q10 · pox commentary fourth quarter 2010 cowpox provided immunity from the...

9
Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven. There is no cure for cowpox, even today, only treatment to relieve a fever and ban- dages to cover the wounds and prevent bac- terial infection. As he was preparing a treat- ment for Sarah, this country doctor scraped some of the pus into a vial, then bandaged her and sent her home to rest. The cowpox virus in hand, he then turned his attention to how he could test his theory. What he discovered and, more importantly, proved, was arguably the greatest advance- ment in human history. Yet his name today is unknown, his achievement unheralded. We’ll rectify that now. We’ll also examine his experiments and the results, and the re- action of the medical establishment to them, for there are lessons there. But there are bigger lessons for us as well, as we confront an increasingly turbulent world. 429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com B lossom was a cow. Nothing special, really, just a cow of the ancient breed of Gloucesters, prized for their excellent milk and cheese. Extracting this precious liquid was, for millennia, tedious, hard work. Before the advent of mechanical milking, about 100 years ago, milkmaids would spend hours drawing milk by hand, frequently de- veloping blisters. There is a common bovine virus that causes pustules to form on the udders and teats of cows, and when exposed skin rubs against a pustule, the virus is transmitted from cow to human, causing similar skin blisters, or pox. On a sunny spring day in May 1796 in Gloucestershire, Sarah Nelmes was milking Blossom, who unfortunately was not feeling well as pustules had broken out all over her udder. Sarah, oblivious to the risk, soon ex- hibited pox on her hands and arms, and went to see the country doctor. This was not your usual doctor. Rather than simply treat his patient, he was eager to test a theory he had been developing. It had long been observed that milkmaids who had con- tracted cowpox did not succumb to the highly contagious and mostly lethal smallpox epidemics that ravaged populations from time immemorial. No one knew why this was so, or even if it were really true, as no methodical study of this observation had ever been conducted. But perhaps, for un- known reasons, contracting and surviving

Upload: others

Post on 12-Mar-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

Pox

Commentary Fourth Quarter 2010

cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven.

There is no cure for cowpox, even today, only treatment to relieve a fever and ban-dages to cover the wounds and prevent bac-terial infection. As he was preparing a treat-ment for Sarah, this country doctor scraped some of the pus into a vial, then bandaged her and sent her home to rest. The cowpox virus in hand, he then turned his attention to how he could test his theory.

What he discovered and, more importantly, proved, was arguably the greatest advance-ment in human history. Yet his name today is unknown, his achievement unheralded. We’ll rectify that now. We’ll also examine his experiments and the results, and the re-action of the medical establishment to them, for there are lessons there. But there are bigger lessons for us as well, as we confront an increasingly turbulent world.

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com

B lossom was a cow. Nothing special, really, just a cow of

the ancient breed of Gloucesters, prized for their excellent milk and cheese. Extracting this precious liquid was, for millennia, tedious, hard work. Before the advent of mechanical milking, about 100 years ago, milkmaids would spend hours drawing milk by hand, frequently de-veloping blisters. There is a common bovine virus that causes pustules to form on the udders and teats of cows, and when exposed skin rubs against a pustule, the virus is transmitted from cow to human, causing similar skin blisters, or pox.

On a sunny spring day in May 1796 in Gloucestershire, Sarah Nelmes was milking Blossom, who unfortunately was not feeling well as pustules had broken out all over her udder. Sarah, oblivious to the risk, soon ex-hibited pox on her hands and arms, and went to see the country doctor.

This was not your usual doctor. Rather than simply treat his patient, he was eager to test a theory he had been developing. It had long been observed that milkmaids who had con-tracted cowpox did not succumb to the highly contagious and mostly lethal smallpox epidemics that ravaged populations from time immemorial. No one knew why this was so, or even if it were really true, as no methodical study of this observation had ever been conducted. But perhaps, for un-known reasons, contracting and surviving

Page 2: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 2

B asking in the glow of Fed chairman Ber-

nanke’s promise to re-open the spigots of monetary policy, equities continued to soar in the final quarter of the year. Conversely, and not coin-cidentally, bond prices plunged on fears that this new liquidity, on top of the old liquidity, would translate into rising infla-tion, as the Fed chairman promised it would. Not every equity market shined in the quarter: poor (literally) Greece lost 11% (for a 46% de-cline in 2010) and Bot-swana, a once-paragon of progress, tumbled, inexplicably, 23%. But mostly, it was good news around the world, with even moribund Japan rising 12% in the last three months of the year. Best of all was the former (about 150 years ago) powerhouse, Argentina, which advanced 26% in the quarter to pace a 70% gain for the year.

Despite a poor quarter, bonds posted a decent year as the sovereign debt crisis in Europe that bloomed (erupted) in the spring pushed core gov-ernment yields lower. Looking back, bond inves-tors benefited from spread compression in 2009, and then lower yields in a flight-to-quality in 2010. But 2011 may be a challenge: spreads are tight and yields are low, so prospective returns appear slim. But the yield curve (the spread be-

tween short- and long-term yields) is very steep (record steep), and a decent return can be had by extending duration and rolling down that curve, even if yields are low. His-tory is instructive: cash earned about ½ per-cent per annum in the 1930s, but govern-ment bonds returned 5% p.a. (and 7% p.a. from corporate bonds). Of course, extend-

“Basking in the glow...”

Commentary Fourth Quarter 2010

Source: U.S. Department of Labor: Bureau of Labor Statistics

Consumer Price Index for All Urban Consumers Housing (CPIHOSSL)

2

Capital Market Performance

1

Global Equities US Bonds Global REITS

9.4%

14.4%

3.9%

- 1.3%

6.5%5.8%6.2%

20.4%

2.9%

- 5.0%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

4Q10 1-Year 5-Years

20.0

17.5

15.0

12.5

10.0

7.5

5.0

2.5

0.0

-2.5

(% C

hang

e fr

om Y

ear

Ago

)

1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 2015

Shaded areas indicate US recessions2010 research.stlouisfed.org

Page 3: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

ing duration when yields are low carries its own risks, all of which is to say that bond investors will have to choose their poison carefully (and have the antidote handy).

I nflation is an increasing concern among investors, partly because the “visible” components of the CPI, items

that are frequently purchased, such as food and gasoline, are clearly rising in price. Less visible are the infrequent big-ticket pur-chases, such as automobiles and appliances, or more importantly, housing, which ac-counts for one-third of the index weight. As we all know, this component has been deflating (see Chart 2, page 2).

Food inflation should not be dismissed, though. While it represents less than 10% of the US CPI, food comprises a significant per-centage of spending in most countries: one-quarter of all purchases in Japan and India, for example, more than one-third in China, Russia and Indonesia (see Chart 3).

Supply and demand factors are both at play. Supply is as tight as we’ve seen in nearly 40 years: stocks of coffee, sugar and cotton are one-third lower than average, and wheat, rice, corn, beef and hogs are all also much tighter than normal. In response, Russia, which has had its worst drought in 130 years, has banned all wheat exports, Ukraine has imposed export quotas, and India has banned cotton exports, all of which serve to exacerbate shortages. It is no surprise, then, that food prices are at their highest in at least 20 years (when the UN began tracking the data—see Chart 4).

While supplies are squeezed, demand is growing, a structural phenomenon that will continue for years (decades) to come. There is a well-documented, close correlation be-tween incomes and protein consumption, across cultures and throughout the centu-ries. This is manifested by rising meat con-sumption, and meats are much more re-source-intensive than grains: one pound of

beef requires eleven pounds of grain (and seven pounds for pork and three pounds for chicken), in addition to a lot more water. Most meat is produced locally, because it is expensive to refrigerate and ship, but grain is traded globally. The good news (for Ameri-cans, at least) is that the US accounts for more than a third of world production of corn and soybeans, and around half of world exports of these grains.

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 3

Commentary Fourth Quarter 2010

3

Food as a Percentage of Spending

Source: Credit Suisse

4

FAO Food Price Index

2002-2004=100230

200

170

140

110

2008 2010

2007

2009

2006

J F M A M J J A S O N D

Source: UN FAO

US

Euro

pe UK

Aus

tral

iaK

orea

Bra

zil

Mex

ico

Sin

gapo

reTa

iwan

Pola

ndS

. Afr

ica

Japa

nH

ong

Kon

gIn

dia

Chi

leTu

rkey

Col

ombi

aA

rgen

tina

Mal

aysi

aC

hina

Thai

land

Rus

sia

Indo

nesi

aPh

ilipp

ines

Emerging markets much more exposed to a bout of food price inflation

60.0

50.0

40.0

30.0

20.0

10.0

0.0

Page 4: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

As noted, food is a small part of US consumer spending, but much greater for the rest of the world, with impor-tant political and economic implica-tions. It is no coincidence that the political upheavals in Tunisia and Egypt followed spikes in food prices. This is not lost on the leadership of other countries as they attempt to stockpile inventory: Algeria bought 800,000 tons of wheat last month, Indonesia has ordered 800,000 tons of rice, and Saudi Arabia, Libya and Bangladesh are all trying to secure extra grain sup-

plies. Their political lives (not to mention the lives of their populace) may depend on it.

Rising food prices should be seen in the con-text of loose monetary policy in much of the developing world. Inflation is an increase in the general level of prices, not a higher price for any single good, and a rise in the general level of prices can only be caused by an ex-cess supply of money relative to demand, which is what we find in much of the devel-oping world. Core inflation (the measure that excludes food and energy) is running around 1% p.a. in the developed world, but is at 4% (and climbing) in the emerging mar-kets. In most developing countries, interest rates are well below nominal GDP growth (Brazil is an exception, see Table 1), indica-tive of (too) loose monetary policy.

Investors fear the inflation virus may find its way from emerging markets to the devel-oped world, principally via higher import prices. But the correlation between inflation in the developing and the developed world is, at best, modest, and the linkage between import prices and core inflation is, essen-tially, zero (although it is tighter with head-line inflation due to the effect of oil im-ports—see Table 2).

We don’t doubt inflation will rise in the U.S., mostly because the Federal Reserve so wills it. The decline in the inflation rate in the U.S. is a function of lack of demand for money, not a shortage of supply. As the economy

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 4

Commentary Fourth Quarter 2010

“...the inflation virus...”

Table1

Bond Yields Below Nominal GDP Growth

Correlations with EM and Chinese Headline Inflation Remain Low

1995-2010 2000-2010EM China EM China

Headline inflationUS 0.10 0.33 0.43 0.40

Euroland -0.00 0.40 0.65 0.51Japan 0.11 0.17 0.21 0.39

Core inflationUS 0.41 0.27 0.26 0.02

Euroland -0.10 0.33 0.43 0.30Japan 0.22 0.10 0.08 0.13

Import PricesUS -0.02 0.35 0.41 0.55

Euroland -0.14 0.23 0.29 0.34Japan -0.11 0.25 0.33 0.37

Addendum: Correlation of Import Prices with Core and HeadlineCore Headline Core Headline

US 0.11 0.81 0.19 0.84Euroland 0.10 0.69 0.09 0.70

Japan -0.10 0.25 0.19 0.56

Source: GS Global ECS Research

5 Output Gaps Lead Core

Inflation in Developed Economics

3

2

1

0

-1

-2

-3

-4

-5

-697 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12

Output Gap (1-year lead lhs)Core inflation (rhs)

Developed Economies 2.5

2.0

1.5

1.0

0.5

0.0

% of potentialOutput yoy%

Source: Thomson Reuters, CIU estimates, Credit Suisse research

All series are calculated as quarter-on-quarter annualized percent changes; Source: GS Global FCS Research

CountryLong Term

RateReal GDP growth

(2011 EU estimate)Nominal GDP

GrowthLT rate – Nominal

GDP GrowthChina 3.9 8.9 14.0 -10.1India 8.1 8.6 16.9 -8.8Russia 5.9 4.0 12.1 -6.2Indonesia 7.5 6.0 13.0 -5.4Singapore 2.7 4.1 7.9 -5.3Hong Kong 2.8 4.4 7.3 -4.5Thailand 3.7 4.3 7.4 -3.7Korea 4.7 3.9 7.4 -2.7Brazil 12.4 4.6 10.5 1.8Average 5.7 5.4 10.7 -5.0

Table2

Page 5: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

as part of a broader monetary tightening to contain inflation in the emerging world. This would have important implications for the developed world, as the necessity of having to recycle export earnings diminishes, reduc-ing the marginal purchases of foreign (i.e., our) bonds. At a time when our own eco-nomic recovery is tenuous, less demand for our debt as creditor countries shift policies to combat domestic inflation may come as bitter medicine.

A ccelerating economic growth through an export-led strategy of maintaining an undervalued ex-

change rate and providing cheap credit to the consumer markets has been central to the development success of emerging econo-mies for the past two decades. Developing countries have accumulated trillions of dol-lars of foreign reserves while running ever growing current account surpluses, while consumer economies (principally, the U.S.) ran offsetting deficits (see Chart 6). The fi-nancial crisis of 2008 reduced these imbal-ances, but only temporarily, as they are ex-pected to increase again as the old policies return (see Chart 7, page 6). But policies that have been successful in the past are not necessarily optimal in the future, especially as they come with growing costs, in the form of higher inflation. Official projections (see Chart 7, page 6) are always smooth and

marginal, but the rising political and economic costs may prompt a pol-icy shift.

Developing countries are not alone in confronting the mounting costs of past policies. Europe is fracturing along its core and periphery, and even that fault line is shifting. Rising debt burdens in the periphery have pushed markets to limit access to capital through rising credit spreads (see Chart 8, page 6). Greece would have to pay nearly 12% to borrow long-term in the markets, Ireland around 8%, Portugal around

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 5

Commentary Fourth Quarter 2010

“Europe is fracturing

along its core and

periphery...”

(and the banks) recover, and they are, the velocity of money1 will pick up (we’re begin-ning to see signs of this) and inflation will move higher. For now, though, there is suffi-cient slack in the U.S. economy to keep infla-tion contained near-term (see Chart 5, page 4).

Historically, the developed world has been insulated from high inflation in the emerging world via floating exchange rates. The very high (100%) inflation rate in emerging mar-kets in the early 1990s, for example, led to depreciating nominal EM exchange rates, not to higher inflation in developed economies. Today, however, the manipulation (sorry, management) of exchange rates, most nota-bly by China, has prevented this currency adjustment. The result is rising domestic inflation that has not (yet) jumped the oceans to the US and Europe. Absent a forthcoming currency adjustment, though, inflation pressures will build.

Rising inflation in the emerging economies highlights the urgency of examining the growth model of low exchange rates and burgeoning foreign reserves. The surge in food prices may be the catalyst for a change, where currencies are permitted to revalue

Source: McKinsey Global Economic Database; McKinsey Global Institute

Cumulative current account balances, 2005-09

6

Current account surpluses Current account deficits

0.6 0.5 0.3 0.2 0.1 - - - -0.1 -0.1 -1.3

China Rest Middle WesternAfrica Canada Latin India Oceania Eastern USof Asia East Europe America Europe

1.519 1.360

706425 301

96

-77 -91 -269 -380

-3.316

% of cumulative world, GDP, 2005-09

$ billion

1 The equation is MV=PQ, where M is money supply, V is velocity, P is the price level and Q is the output of goods.

Page 6: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 6

Commentary Fourth Quarter 2010

as current spreads suggest a greater-than-50% likelihood of default). Portugal has not been able to grow much over the past dec-ade, and its higher inflation rate coupled with an appreciating euro has caused the country to lose price competiveness. Spain, on the other hand, has grown too quickly; bank credit to the private sector trebled between 1998 and 2008. Italy has grown at a rate even less than Portugal and has a debt/GDP ratio of 130%, behind only Greece. But its budget deficit is modest and might even see surpluses this year and next, thus stabilizing the debt/GDP ratio. Belgium is a core coun-try that is at risk of moving to the periphery. Its economy has been growing and house-hold debt is relatively low. But its banking system is broken, and with banking assets equal to 350% of GDP, Belgians cannot solve this problem themselves. France and the Netherlands stepped in to unwind Fortis, Belgium’s largest financial institution, and France and Luxembourg provided capital to Dexia, the other Belgian financial giant. Po-litically, the country is split, and has not had an effective government since June.

This coming year will test the resolve of these countries and the markets, for there are large borrowing needs ahead (see Chart 9, page 7). Portugal will need to redeem €30 billion this year, Spain has €150 billion due, and Italy must refinance €340 billion. As we’ve seen, tapping the capital markets for these funds is problematic given the high cost. Germany can continue to provide funds for liquidity, but there may be limits to German largesse. Regardless, providing li-quidity doesn’t address the solvency issue, how these countries will be able to grow at rates greater than their cost of debt, and thus begin to reduce their debt burdens. Restructuring is the polite term for default, but whatever it’s called, the laws of mathe-matics must be obeyed, and strong political leadership will be required to mitigate collat-eral damage.

7%. Their economies are not growing (and will not grow) at nominal rates high enough to service this cost of debt.

The peripheral countries share a rising debt burden and bleak prospects for growing out of them, but each has its own dynamic, re-quiring different responses, made more chal-lenging as monetary policy is out of their hands. Greece is effectively bankrupt, with deep-rooted, structural problems that ap-pear hopeless to remedy (that may be an opinion, but one the markets seem to share

Source: IMF staff estimates. 1 CHN+EMA: China, Hong Kong SAR, Indonesia, Korea, Malaysia, Philippines, Singapore, Taiwan Province of China, and Thailand; DEU+JPN: Germany and Japan; OCADC, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Ireland, Latvia, Lithuania, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Turkey, and United Kingdom; OIL, Oil exporters; ROW, rest of the world; US: United States

4

3

2

1

0

-1

-2

-31996 98 2000 02 04 06 08 10 12 14 15

DEU+JPNOCADCOILCHN+EMAROWUS

Discrepancy

Global Imbalances1

(Percent of world GDP)

7

Source: Bloomberg L.P.

Sovereign Credit Default Swap Spreads (in basis points)

8

1200

1000

800

600

400

200

0

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan2010

GreeceIrelandPortugalSpainItalyBelgiumFranceUnited KingdomJapanGermanyUnited States

Page 7: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

Commentary Fourth Quarter 2010

“Small pox has been mankind’s deadliest scourge.”

A s developed countries strug-gle with debt burdens, emerging countries may be

poised for a massive investment boom, similar in magnitude and im-pact as the Industrial Revolution or the post-World War 2 boom. As countries develop, their capital stock increases (see Chart 10), funded by a drawdown of their savings (see Chart 11). McKinsey projects global investment more than doubling from $11 trillion today to $24 trillion by 2030 as these economies continue to expand.

This coming investment boom in emerging economies, should it come to pass, would become the principal driver of the world economy over the next few decades, taking that mantel from the U.S. consumer. It would also mean the end of more than 30 years of a declining cost of capital (see Chart 12, page 8). Con-trary to the claim (made by Ber-nanke, i.a.) that a “savings glut” was responsible for the declining cost of capital, the global savings rate actu-ally fell between 1970 and 2002, from 23% of global GDP to 19.6%. Over the same period, capital invest-ment fell from 26.1% to 20.8% of world GDP. The world has been under-investing, not over-saving. Should capital investments begin to rise in the emerging world, as seems likely, the cost of capital will also rise. Good for savers, but a challenge for companies and countries that have been dependent on cheap capi-tal to fuel growth.

S mallpox has been mankind’s deadliest scourge. There is evidence of it afflicting humans

more than 12,000 years ago. Egyp-tian mummies from 3,500 years ago show evidence of its lesions. The

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 7

1 Stock of net fixed assets at the end of the year, assuming 5 percent depreciation rate for all the assets. Source: McKinsey insights China; McKinsey Global Economic Database; McKinsey Global Institute

10

Capital stock vs. GDP per capita by Country and year, 1980-2008

$thousand, sample of selected countries, constant 2005 prices and exchange rates

140

120

100

80

60

40

20

00 5,000 10,000 15,000 20,000 25,000 30,000 35,0000 40,000 45,000

India

China

UrbanChina

South Korea

Italy

Japan

Germany

UK

US

Capital stock per capita1

1 Constant 2005 prices and exchange rates. Source: Bank of Japan, Bank of Korea; Directorate-General Budge Accounting and Statistics, Republic of China; Global Insight; McKinsey Insights China; McKinsey Global Economic Growth Database; Reserve Bank of India; US Bureau of Economic Analysis; World Development; Indicators of the World Bank; McKinsey Global

11

40

35

30

25

20

15

10

5

0

-50 5 10 15 20 25 30 35 40 45

India

China

S. Korea

Japan

Taiwan

Germany

US

Saving rate% of disposable personal income

GDP per capita$ thousand, real1

Household saving rate vs. GDP per capita 1960-2008

Government and Bank Bonds Due 9

2007 2011

Bank

Government

14

12

10

8

6

4

2

0Greece Italy Japan Portugal Spain Belgium United France Germany United Ireland

Kingdom States

Source: Dealogic, IMF, World Economic Outlook database and IMF staff calculations. Note: The first stacked bar for each country is for bonds that were due in 2007 and the second stacked bar is for bonds due in 2011. In order to compare current funding needs with the past, dataset only includes a subset of total bonds due and so does not reflect total funding needs. The chart also does not include interest pay-ments.

Page 8: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 8

Commentary Fourth Quarter 2010

more fortunate for James Phipps), he wasn’t wrong. In fact, James survived each of the smallpox epidemics that periodically ravaged the country.

The doctor recorded his observa-tions and findings in a note to the Royal Society, the most prestigious scientific body in the world. The pa-per was rejected without comment. He continued with his experiments on more subjects, and self-published his paper the following year. The Latin word for cow is vacca, and he decided to call his procedure vacci-nation.

He spent his last 25 years trying to convince one doctor at a time to embrace his vaccination method.

Grudgingly, it found acceptance. In 1840, 17 years after his death, the Royal Society de-clared that it was the only approved method of prevention. In 1967, the World Health Organization began a global campaign to eradicate smallpox, and declared victory in 1980, more than 180 years, and hundreds of millions of deaths, after vaccination was proven effective.

We draw three lessons from this story. The first is not to trust blindly the experts. They tend to see the world through their own prisms of success, making it difficult to see events from a perspective that challenges their own world view. Secondly, a little bit of discomfort now can fore-stall a lot more pain in the future. This advice applies to dic-tators sup-pressing de-mocracy, as well as to de-mocrats (small d) accu-

disease is mentioned in the ancient Sanskrit texts of India, and was described more than 3,000 years ago in China. It was unknown in the Americas until introduced by European conquerors. The disease wiped out most of the Aztec and Inca peoples; it is a truism that swords did not conquer the natives of the Americas, smallpox did. In the 18th cen-tury, 400 million Europeans died from the disease, and a third of those survivors were blinded. Even in the 20th century, 300-500 million died from this disease. Smallpox is, by far, the greatest killer of humans in all his-tory, the destroyer of vast civilizations.

James Phipps was a healthy eight year-old boy when the country doctor rode out to the Phipps’ farm to speak to James’ father. The doctor explained that he carried a vial of the cowpox, and wanted permission to infect James with it. He said James would get sick, but would recover and would forever thereafter be immune to the smallpox virus. For reasons lost to history, James’ father agreed, and the doctor made two incisions on James’ left arm and poured the pus from Sarah Nelmes’ pox into the open wounds. Had he been wrong, the doctor would be guilty of murder. Fortunately for him (and

1 US 10-year government bonds; UK 10- and 20-year government bonds. 2 Calculated as: nominal yield on 10-year bonds in current year minus average realized inflation over next 10 years. We use OECD estimates of inflation in 2010-19 to estimate real interest rates in 2001-09. Source: Ferguson (2008); MeasurementWorth; International Monetary Fund International Financial Statistics; Organization for Economic Co-operation and Development; McKinsey Global Institute.

12

UK and US real interest rates varied significantly since 1870; currently, they are very low levels.

16

1412

108

6

42

0

-2

-4

-6-8

1870 75 80 85 90 95 1900 05 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 2000 05 09

US ex-post real values2

UK ex-post real value2

US nominal valuesUK nominal values

Second IndustrialRevolution

WW I & II andinterwar years

Bretton WoodsSystems

Moderate growthand inflation

targeting

Oil crisis (inflation)

Long-term interest rates in the US and UKYield to redemption on long-term government bonds,1 1870-2009

Page 9: Angeles Commentary 4Q10 · Pox Commentary Fourth Quarter 2010 cowpox provided immunity from the deadly smallpox disease. This had been suspected by others, but never tested and proven

Commentary Fourth Quarter 2010

“Jefferson was

wrong...”

mulating evermore debt. Thirdly, as we measure human development not by years but across centuries and millennia, it is clear that technological advancement holds the key to human progress. More (or less) gov-ernment spending, higher (or lower) taxes merely shuffle the deck; technological break-throughs advance our civilization.

In 1806, President Thomas Jefferson wrote this letter from his home in Monticello:

Unfortunately, Jefferson was wrong. In a quiet corner of Kensington Gardens, Lon-don, millions each year walk past a statue, oblivious to who he is or why he is honored. In ignorance or in haste, they are unaware that he is the father of immunology, the man responsible for eradicating the deadliest dis-ease in human history, thereby saving more lives than any person has ever done, or likely ever will: Dr. Edward Jenner.

429 Santa Monica Blvd., Ste 500 • Santa Monica • California • 90401 • p (310) 393-6300 • f (310) 393-6200 • www.angelesadvisors.com Page 9

Founded in 2001, Angeles Investment Advisors LLC provides investment advice to select institutions and high net worth families and individuals.

MICHAEL A. ROSEN PRINCIPAL & CHIEF INVESTMENT OFFICER

FEBRUARY 2011

This report is not an offer to sell or a solicitation to buy any security. This is intended for the general information of the clients of Angeles Investment Advisors. It does not consider the investment objectives, financial situation or needs of individual investors. Before acting on any advice or recommendation in this material, a client must consider its suitability and seek professional advice, if necessary. The material contained herein is based on information we believe to be reliable, but we do not represent that it is complete or accurate, and it should not be relied on as such. Opinions expressed are our current opinions as of the date written only, and may change without notification. We, along with any affiliates, officers, directors or employees, may, from time to time, have positions, long or short, in, and buy and sell, any securities or derivatives mentioned herein. No part of this material may be copied or duplicated in any form by any means and may not be redistributed without the consent of Angeles Investment Advisors, LLC.

If you would like to receive a copy of our Form ADV Part II free of charge, please email Steve Smetana at [email protected], or call Mr. Smetana at our main number: (310) 393-6300.

© 2011 Angeles Investment Advisors, LLC All Rights Reserved.

SIR,

I have received a copy of the evidence at large respecting the discovery of the vaccine inoculation which you have been pleased to send me, and for which I return you my thanks.

Having been among the early converts, in this part of the globe, to its efficiency, I took an early part in recommending it to my countrymen. I avail myself of this occasion of rendering you a portion of the tribute of gratitude due to you from the whole human family. Medicine has never before produced any single improvement of such utility. Harvey's discovery of the circulation of the blood was a beautiful addition to our knowledge of the animal economy, but on a review of the practice of medicine before and since that epoch, I do not see any great amelioration which has been derived from that discovery. You have erased from the calendar of human afflictions one of its greatest. Yours is the comfortable reflection that mankind can never forget that you have lived. Future na-tions will know by history only that the loathsome small-pox has existed and by you has been extir-pated.

Accept my fervent wishes for your health and happiness and assurances of the greatest respect and consideration.